New lipid guidelines focus on LDL targetsOther changes include new roles for C-reactive protein and apo B, as well as a modified risk calculation Raising HDL beats further LDL loweringBut controversial add-on drug trial measured plaque buildup, not clinical endpoints Off-pump bypass comes up short New lipid guidelines focus on LDL targets Everolimus-eluting stent goes to head of class Long-term BP control achieved with renal nerve ablation Experimental procedure has helped patients with refractory hypertension without causing adverse effects on kidney Doubling clopidogrel dose makes for safer angioplasty Decrease in heart attack and thrombosis risk outweighs rise in severe bleeding: Canadian study New antiplatelet agent reduces cardiovascular events Pregnancy feasible for heart recipients But better counselling needed on drug risks and long-term maternal survival Ezetimibe-atorvastatin combo proves effective First Previous 90 91 92 93 94 Next Last
